Shire ends pacritinib development deal with CTI post Baxalta merger
Shire has abandoned its partnership on CTI BioPharma’s oral kinase inhibitor pacritinib seven months after deaths in a Phase III trial halted its clinical development.
Archives for September 19, 2016
Almac Group announces $5.2m expansion
In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.
Plasticell and CellSpring collaborate on high performance drug screening
The collaboration combines Plasticell’s cell culture media for creating fat and bone cells in 2-dimensional cell cultures, with CellSpring’s high throughput 3-dimensional screening assays for drug discovery.
CDMO Custom Pharma Services expands operations
The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.
Sarepta looks to scale up production on back of its DMD drug success
Sarepta Therapeutics says it is considering selling its FDA priority review voucher to support manufacturing scale-up for Exondys 51, its approved Duchenne Muscular Dystrophy drug.
Johnson Matthey's refurbished Annan API plant passes MHRA GMP inspection
The UK MHRA has awarded Johnson Matthey’s API facility in Scotland a GMP certificate.